Arkolith/Insider Trading/PRTK/Form 4

Brenner Randall B.

Chief Development & RegulatoryParatek Pharmaceuticals, Inc. (PRTK) · full profile →Form 4 · filed Dec 14, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$58K
Net Open-Market Flow
-$58K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2022Sell(S)18K$1.96$36K325K
Dec 12, 2022Sell(S)11K$1.98$22K343K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000904454-22-000623) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML